The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden and underdiagnosis. India's pharmaceutical industry is poised ...

The Quarterly Results page of Cipla Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

MONTREAL - Quebec’s maple syrup producers are worried their industry will take a big hit if U.S. President Donald Trump goes ahead with his threat to slap 25 per cent tariffs on Canadian exports ...

UNIVERSITY PARK — Interested in learning to make maple syrup from start to finish ... Click the image to view the latest e-edition. Don't have a subscription? Click here to see our subscription ...